Tonix Pharma In-Licenses Drug to Treat Cocaine Intoxication

Tonix Pharma In-Licenses Drug to Treat Cocaine Intoxication

Submitted by admin on May 24, 2019 - 11:43pm
Source: 
BioSpace
News Tags: 
Tonix Pharmaceuticals
TNX-1300
cocaine addiction
Headline: 
Tonix Pharma In-Licenses Drug to Treat Cocaine Intoxication
snippet: 

New York City-based Tonix Pharmaceuticals announced it has in-licensed a Phase II drug, TNX-1300, from Columbia University. TNX-1300 is a recombinant enzyme that degrades and metabolizes cocaine in cocaine abusers.

Do Not Allow Advertisers to Use My Personal information